Cargando…

SIRT1 gene polymorphisms and risk of lung cancer

OBJECTIVE: Lung cancer, which is the leading cause of cancer death worldwide, is influenced by a wide variety of environmental and genetic risk factors. The silent information regulator 1 (SIRT1) gene is located on the long arm of chromosome 10 (10q21.3) and has been shown to play crucial roles in l...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Yanbo, Lin, Shuangyan, Peng, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590763/
https://www.ncbi.nlm.nih.gov/pubmed/28919817
http://dx.doi.org/10.2147/CMAR.S142677
_version_ 1783262582161801216
author Lv, Yanbo
Lin, Shuangyan
Peng, Fang
author_facet Lv, Yanbo
Lin, Shuangyan
Peng, Fang
author_sort Lv, Yanbo
collection PubMed
description OBJECTIVE: Lung cancer, which is the leading cause of cancer death worldwide, is influenced by a wide variety of environmental and genetic risk factors. The silent information regulator 1 (SIRT1) gene is located on the long arm of chromosome 10 (10q21.3) and has been shown to play crucial roles in lung cancer development in previous studies. In this study, we determined whether variation in the SIRT1 gene is associated with lung cancer in Chinese population. METHODS: The case–control study comprised 246 controls and 257 non-small cell lung cancer patients, comprising 79 squamous cell carcinoma patients and 124 adenocarcinoma patients. All subjects were from Zhejiang, China. Four single-nucleotide polymorphisms of SIRT1 gene were analyzed: rs12778366 (C/T, lies in the 5′ upstream), rs3758391 (C/T, lies in the 5′ upstream), rs2273773 (C/T, lies in the coding) and rs4746720 (C/T, lies in the 3′ untranslated region). RESULTS: No significant difference of allele and genotype frequencies was observed between the different groups. Haplotype association analysis carried out on the four single-nucleotide polymorphisms within the case–control cohort also did not reveal a significant association with lung cancer (P>0.05). CONCLUSION: The results suggest the tested SIRT1 gene polymorphisms may not contribute to lung cancer. Further studies are warranted to demonstrate the functional roles of the SIRT1 polymorphism in lung cancer.
format Online
Article
Text
id pubmed-5590763
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-55907632017-09-15 SIRT1 gene polymorphisms and risk of lung cancer Lv, Yanbo Lin, Shuangyan Peng, Fang Cancer Manag Res Original Research OBJECTIVE: Lung cancer, which is the leading cause of cancer death worldwide, is influenced by a wide variety of environmental and genetic risk factors. The silent information regulator 1 (SIRT1) gene is located on the long arm of chromosome 10 (10q21.3) and has been shown to play crucial roles in lung cancer development in previous studies. In this study, we determined whether variation in the SIRT1 gene is associated with lung cancer in Chinese population. METHODS: The case–control study comprised 246 controls and 257 non-small cell lung cancer patients, comprising 79 squamous cell carcinoma patients and 124 adenocarcinoma patients. All subjects were from Zhejiang, China. Four single-nucleotide polymorphisms of SIRT1 gene were analyzed: rs12778366 (C/T, lies in the 5′ upstream), rs3758391 (C/T, lies in the 5′ upstream), rs2273773 (C/T, lies in the coding) and rs4746720 (C/T, lies in the 3′ untranslated region). RESULTS: No significant difference of allele and genotype frequencies was observed between the different groups. Haplotype association analysis carried out on the four single-nucleotide polymorphisms within the case–control cohort also did not reveal a significant association with lung cancer (P>0.05). CONCLUSION: The results suggest the tested SIRT1 gene polymorphisms may not contribute to lung cancer. Further studies are warranted to demonstrate the functional roles of the SIRT1 polymorphism in lung cancer. Dove Medical Press 2017-09-04 /pmc/articles/PMC5590763/ /pubmed/28919817 http://dx.doi.org/10.2147/CMAR.S142677 Text en © 2017 Lv et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Lv, Yanbo
Lin, Shuangyan
Peng, Fang
SIRT1 gene polymorphisms and risk of lung cancer
title SIRT1 gene polymorphisms and risk of lung cancer
title_full SIRT1 gene polymorphisms and risk of lung cancer
title_fullStr SIRT1 gene polymorphisms and risk of lung cancer
title_full_unstemmed SIRT1 gene polymorphisms and risk of lung cancer
title_short SIRT1 gene polymorphisms and risk of lung cancer
title_sort sirt1 gene polymorphisms and risk of lung cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590763/
https://www.ncbi.nlm.nih.gov/pubmed/28919817
http://dx.doi.org/10.2147/CMAR.S142677
work_keys_str_mv AT lvyanbo sirt1genepolymorphismsandriskoflungcancer
AT linshuangyan sirt1genepolymorphismsandriskoflungcancer
AT pengfang sirt1genepolymorphismsandriskoflungcancer